Impact Biomedicines

More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
M&A
biotech
Celgene
Sanofi
Impact Biomedicines
Bioverativ
GSK
Takeda
Shire
JNJ
Why Impact Biomedicines Could Be Celgene’s Next Embarrassment
NY Shock Exchange
Mon, 06/18/18 - 01:12 pm
Celgene
Impact Biomedicines
5 Things Celgene's Management Just Said That You'll Want to Know
Motley Fool
Sat, 01/27/18 - 09:39 am
Celgene
M&A
Juno Therapeutics
Impact Biomedicines
Otezla
drug pricing
Celgene's task: Turn its shiny new toys into growth drivers
Biopharma Dive
Thu, 01/25/18 - 05:51 pm
Celgene
M&A
Juno Therapeutics
Impact Biomedicines
Celgene aims to quell growth worries with $7B Impact deal
Biopharma Dive
Mon, 01/8/18 - 11:27 am
Celgene
Impact Biomedicines
M&A
Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
Endpoints
Fri, 10/13/17 - 09:52 am
Sanofi
myelofibrosis
fedratinib
Impact Biomedicines